SCHEMBL31410845

SCHEMBL31410845

CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.56
▸ NPY4R P50391 13/20 0.51
▸ NPY1R P25929 9/20 0.51
▸ NPY5R Q15761 8/20 0.51
▸ NPY2R P49146 5/20 0.51
▸ VIPR1 P32241 1/20 0.47
▸ IL23R Q5VWK5 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31307284 0.93 TFPI (0.56) TFPINPY4RNPY1RNPY5RNPY2R
SCHEMBL30198602 0.88 TFPI (0.56) TFPINPY4RNPY1RNPY5RVIPR1
SCHEMBL30607413 0.88 TFPI (0.66) TFPINPY4RNPY1RNPY5RNPY2R
SCHEMBL30242239 0.86 TFPI (0.54) TFPINPY4RNPY1RNPY5RNPY2R
SCHEMBL30887558 0.86 NPY4R (0.59) TFPINPY4RNPY1RNPY5RNPY2R
SCHEMBL30257868 0.84 NPY4R (0.63) TFPINPY4RNPY1RNPY5RNPY2R
SCHEMBL10535233 0.84 TFPI (0.62) TFPINPY4RNPY1RNPY5RNPY2R
SCHEMBL10535214 0.84 TFPI (0.62) TFPINPY4RNPY1RNPY5RNPY2R
SCHEMBL3218913 0.84 IL23R (0.49) NPY4RNPY1RNPY5RIL23R
SCHEMBL3218833 0.84 IL23R (0.49) NPY4RNPY1RNPY5RIL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025002589-A1 TISSUE EXTRACELLULAR PEPTIDE PATTERNS DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST SALIVARY GLAND TUMOR, IDENTIFICATION AND ISOLATION OF SALIVARY GLAND TUMOR SPECIFIC T CELLS IN HUMANS Uniwersytet Gdański (PL) 2025-01-02 — — WO disclosed
Send feedback